These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort. Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016 [TBL] [Abstract][Full Text] [Related]
6. Path Integration Changes as a Cognitive Marker for Vascular Cognitive Impairment?-A Pilot Study. Lowry E; Puthusseryppady V; Coughlan G; Jeffs S; Hornberger M Front Hum Neurosci; 2020; 14():131. PubMed ID: 32372934 [TBL] [Abstract][Full Text] [Related]
7. Clinical presentations and epidemiology of vascular dementia. Smith EE Clin Sci (Lond); 2017 Jun; 131(11):1059-1068. PubMed ID: 28515342 [TBL] [Abstract][Full Text] [Related]
8. APOE genotype, vascular risk factors, memory test performance and the five-year risk of vascular cognitive impairment or Alzheimer's disease. Klages JD; Fisk JD; Rockwood K Dement Geriatr Cogn Disord; 2005; 20(5):292-7. PubMed ID: 16166776 [TBL] [Abstract][Full Text] [Related]
9. Vascular cognitive impairment (VCI): Progress towards knowledge and treatment. Di Legge S; Hachinski V Dement Neuropsychol; 2010; 4(1):4-13. PubMed ID: 29213654 [TBL] [Abstract][Full Text] [Related]
10. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. Román GC; Sachdev P; Royall DR; Bullock RA; Orgogozo JM; López-Pousa S; Arizaga R; Wallin A J Neurol Sci; 2004 Nov; 226(1-2):81-7. PubMed ID: 15537526 [TBL] [Abstract][Full Text] [Related]
11. Structural network efficiency mediates the association between glymphatic function and cognition in mild VCI: a DTI-ALPS study. Song H; Ruan Z; Gao L; Lv D; Sun D; Li Z; Zhang R; Zhou X; Xu H; Zhang J Front Aging Neurosci; 2022; 14():974114. PubMed ID: 36466598 [No Abstract] [Full Text] [Related]
12. Understanding brain function in vascular cognitive impairment and dementia with EEG and MEG: A systematic review. Torres-Simón L; Doval S; Nebreda A; Llinas SJ; Marsh EB; Maestú F Neuroimage Clin; 2022; 35():103040. PubMed ID: 35653914 [TBL] [Abstract][Full Text] [Related]
14. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report. Wallin A; Kapaki E; Boban M; Engelborghs S; Hermann DM; Huisa B; Jonsson M; Kramberger MG; Lossi L; Malojcic B; Mehrabian S; Merighi A; Mukaetova-Ladinska EB; Paraskevas GP; Popescu BO; Ravid R; Traykov L; Tsivgoulis G; Weinstein G; Korczyn A; Bjerke M; Rosenberg G BMC Neurol; 2017 May; 17(1):102. PubMed ID: 28535786 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder. Isernia S; Cabinio M; Di Tella S; Pazzi S; Vannetti F; Gerli F; Mosca IE; Lombardi G; Macchi C; Sorbi S; Baglio F J Alzheimers Dis; 2021; 83(4):1789-1801. PubMed ID: 34459394 [TBL] [Abstract][Full Text] [Related]
16. Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health. Kalaria RN; Akinyemi RO; Paddick SM; Ihara M Expert Rev Neurother; 2024; 24(1):25-44. PubMed ID: 37916306 [TBL] [Abstract][Full Text] [Related]
17. Vascular cognitive impairment: Advances in clinical research and management. You T; Wang Y; Chen S; Dong Q; Yu J; Cui M Chin Med J (Engl); 2024 Jul; ():. PubMed ID: 39048312 [TBL] [Abstract][Full Text] [Related]